Tang Capital Management »

Gossamer Bio shares owned by Tang Capital Management

Quarter-by-quarter ownership of Gossamer Bio shares owned by Tang Capital Management from 13F filings

Historical chart of Tang Capital Management investment in Gossamer Bio

Tip: Access up to 7 years of quarterly data

All positions including Gossamer Bio held by Tang Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gossamer Bio by Tang Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $12M 18M 0.64

More positions owned by Tang Capital Management

Aurinia Pharmaceuticals (AUPH)
Spyre Therapeutics Com New (SYRE)
Mirum Pharmaceuticals (MIRM)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Celcuity (CELC)
Corcept Therapeutics Incorporated (CORT)
Ptc Therapeutics I (PTCT)
Lakefront Biotherapeutics Nv Spon Adr
Capricor Therapeutics Com New (CAPR)
Tarsus Pharmaceuticals (TARS)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Anaptysbio Inc Common (ANAB)
Immunocore Hldgs Ads (IMCR)
Compass Pathways Sponsored Ads (CMPS)
Biosante Pharmaceuticals (ANIP)

View all positions for Tang Capital Management

Top funds holding Gossamer Bio

Tang Capital Management
Highbridge Capital Management
Murchinson
Boothbay Fund Management

View all funds holding Gossamer Bio